Immunotherapy and its resistant and challenges
-
Chair(s):
Yun Yen,
Professor ,The Institute for Cancer Biology and Drug Discovery, Taipei Medical University, TAIPEI, Taiwan
Wan Wan Lin,
Professor, National Taiwan University, Taiwan -
Session description:
Enhance biomarker identification in guiding immunotherapy
Dr Yun Yen
Professor, The Institute for Cancer Biology and Drug Discovery, Taipei Medical University, TAIPEI, TaiwanAntagonists of pregnane X receptor revert resistance of colorectal cancer cells to paclitaxel
Dr Oliver Burk
Principal Investigator, Dr Margarete Fischer-Bosch-Institute of Clinical PharmacologyCombinational therapy in cancer immunotherapy
Professor Kwang-Yu Chang
National Institute of Cancer Research, Miaoli, TaiwanHow to enhance the immunotherapy in colon cancer
Dr Edward Chou
Albert Einstein Cancer Center, New York, The United States of AmericaTargeting protumor secretion factors and PTMs of PD-1 for cancer immunotherapy
Dr Yi-Ching Wang
Chair Professor, Department of Pharmacology & Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University, Taiwan
Speakers
-
Dr Edward ChouAlbert Einstein Cancer Center, New York, The United States of America
-
Dr Oliver BurkPrincipal Investigator, Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology
-
Dr Yi-Ching WangChair Professor, Department of Pharmacology & Institute of Basic Medical Sciences College of Medicine, National Cheng Kung University, Taiwan
-
Dr Yun YenProfessor, The Institute for Cancer Biology and Drug Discovery, Taipei Medical University, TAIPEI, Taiwan
-
Professor Kwang-Yu ChangNational Institute of Cancer Research, Miaoli, Taiwan
Leave A Comment